DEBORAH CARY-LALONDE: Open Payments
NPI 1578087706 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 25 payments from 6 companies in 2025. Trend: 2023 $25 · 2024 $269 · 2025 $895
Food & beverage: $783Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $349 |
| Alkermes, Inc. | 3 | $173 |
| Otsuka America Pharmaceutical, Inc. | 4 | $169 |
| Axsome Therapeutics, Inc. | 1 | $100 |
| Neurocrine BioSciences, Inc. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
Products named: UZEDY, REXULTI, LYBALVI, Auvelity, AUSTEDO XR, INGREZZA, COBENFY, ARISTADA.
Industry payments across NY — which companies pay providers there.
